Neuren Pharmaceuticals Limited
General ticker "NURPF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.8B (TTM average)
Neuren Pharmaceuticals Limited follows the US Stock Market performance with the rate: 28.3%.
Estimated limits based on current volatility of 1.4%: low 8.58$, high 8.82$
Short-term NURPF quotes
Long-term NURPF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | AUD231.93MM | AUD216.83MM | AUD64.61MM |
| Operating Expenses | AUD59.43MM | AUD70.64MM | AUD42.59MM |
| Operating Income | AUD172.49MM | AUD146.19MM | AUD22.02MM |
| Non-Operating Income | AUD32.65MM | AUD36.75MM | AUD16.90MM |
| R&D Expense | AUD26.75MM | AUD32.97MM | AUD36.38MM |
| Income(Loss) | AUD205.14MM | AUD182.94MM | AUD38.91MM |
| Taxes | AUD48.06MM | AUD40.90MM | AUD8.49MM |
| Profit(Loss)* | AUD157.08MM | AUD142.04MM | AUD30.42MM |
| Stockholders Equity | AUD205.21MM | AUD363.90MM | AUD338.32MM |
| Inventory | AUD0.00MM | AUD15.34MM | AUD0.00MM |
| Assets | AUD247.97MM | AUD409.71MM | AUD342.72MM |
| Operating Cash Flow | AUD184.93MM | AUD-11.27MM | AUD125.37MM |
| Capital expenditure | AUD0.04MM | AUD0.01MM | AUD0.04MM |
| Investing Cash Flow | AUD-211.49MM | AUD4.13MM | AUD-87.97MM |
| Financing Cash Flow | AUD3.62MM | AUD-8.78MM | AUD-33.21MM |
| Earnings Per Share** | AUD1.24 | AUD1.09 | AUD0.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.